‘Parkinson’s Diagnosis Is Not A Stop Sign,’ Jesse Jackson Says
Jesse Jackson, who has been a civil rights advocate for 50 years, announced the diagnosis on Friday. The New York Times offers a closer look at the disease.
The independent source for health policy research, polling, and news.
30,701 - 30,720 of 112,177 Results
Jesse Jackson, who has been a civil rights advocate for 50 years, announced the diagnosis on Friday. The New York Times offers a closer look at the disease.
Half of Puerto Rico’s electric grid remains down, leaving many of the island’s 3.4 million residents exposed to the heat and unable to keep food or medicines cool without generators. Doctors are trying to make house calls, but there's only so much they can do. And at the same time, the conditions have exacerbated many residents' medical problems.
The Associated Press puts human faces to the numbers behind the opioid epidemic. In other news, a look at how influence in Washington, D.C., has played a role in the crisis, Purdue wants to settle lawsuits with states, counterfeit pills are sending droves of people to the hospital, why medication-assisted treatment is hard for some to get, and more.
The Department of Veterans Affairs’ internal watchdog issues two reports, finding continued issues with the agency's mental health care services and wait times at a clinic. And news of more problems is reported from Georgia and Colorado facilities. Meanwhile, an advocacy group runs ads critical of the VA's use of dogs in experiments.
At the heart of the debate was whether a hospital assessment that was used to help pay for the program was a tax.
Although the standard Part B premium will stay the same next year, many beneficiaries will still have to pay more because their Social Security checks will increase 2 percent after several years of little or no cost-of-living raise. About 42 percent of recipients will see their premium jump to $134 from $109.
When President Donald Trump cut off subsidies to insurers he inadvertently may have boosted the very law he was trying to undermine. Meanwhile, House Democrats trying to bolster marketing for the health law are being thwarted by arcane rules.
“We don’t think many people would lose insurance if the mandate goes away,” said Deep Banerjee, an analyst at Standard & Poor’s. That runs counter to the hopes of Republican lawmakers, who are counting on a repeal of the mandate to free up billions in federal spending because the government won’t be subsidizing so many customers.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Opinion writers offer a range of thoughts and commentary on how the current GOP tax plan impacts health policy and entitlement programs, as well as other health policy topics.
Here is a selection of recent research.
Media outlets report on news from California, Texas, Connecticut, Georgia, Florida, Louisiana, Massachusetts, Pennsylvania, Virginia, Maryland, Hawaii, Ohio, Minnesota and Iowa.
The vast majority of the economic burden — $43.2 billion — came from losses in the workforce due to deaths from opioids, the analysis found. Meanwhile, another study found that about 10 percent of Americans have overcome a drug or alcohol problem in their lives, which might mean there's good news for treating addiction.
Scientists are moving toward a more nuanced understanding of the disease. In other public health news: CTE, the benefits of exercise, weight-loss operations, heart disease and more.
Federal funding for the Children's Health Insurance Program expired at the end of September and lawmakers say they want to renew it, but they haven't agreed on where to get the money. In other Medicaid news, a study looks at the toll of low reimbursements to doctors, another article explores how the health law's expansion of the program has helped patients overcome medical debt issues and North Carolina releases its enrollment numbers.
The congressional effort is aimed at a rule recently issued by the Trump administration that reduces federal reimbursement for medicines purchased under the federal 340B Drug Discount Program. That program helps boost revenues for hospitals that primarily serve low-income patients. Also in Medicare news, federal officials seek suggestions about lowering drug prices and set some new rules on the Part D drug program. The government also reports that improper payments have fallen.
As the promising field has taken off in the past few years, unregulated clinics have sprung up, charging patients thousands of dollars for untested treatments.
Running the Department of Health and Human Services is notoriously challenging, but lately it has faced widespread criticism that it is unresponsive and neglecting staff advice. Former pharmaceutical executive Alex Azar has been nominated to head the agency and will have his Senate hearing later this month.
More than 60 percent of respondents say they would point the fingers at President Donald Trump and Republicans in Congress, though the poll found a distinct partisan divide.
© 2026 KFF